Hans Clevers (Hubrecht Institute) and David Tuveson (Cold Spring Harbor Laboratory), experts in the field of stem cells and organoids, have written a review that summarizes the use of organoids in cancer research and shines a light on prospects for the future.
* This article was originally published here